Form 8-K - Current report:
SEC Accession No. 0001193125-19-176908
Filing Date
2019-06-20
Accepted
2019-06-20 06:06:04
Documents
7
Period of Report
2019-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d721252d8k.htm 8-K 28161
2 EX-4.1 d721252dex41.htm EX-4.1 101787
3 EX-10.1 d721252dex101.htm EX-10.1 217488
4 EX-10.2 d721252dex102.htm EX-10.2 69046
5 EX-99.1 d721252dex991.htm EX-99.1 18987
6 GRAPHIC g721252g72l33.jpg GRAPHIC 6587
7 GRAPHIC g721252g97t41.jpg GRAPHIC 6945
  Complete submission text file 0001193125-19-176908.txt   456569
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35932 | Film No.: 19907418
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 19907419
SIC: 2834 Pharmaceutical Preparations